Sunflower Pharmaceutical Group (002737.SZ): The compound polyethylene glycol (3350) electrolyte oral solution has obtained a drug registration certificate.
Kuibao Pharmaceutical (002737.SZ) announces that its subsidiary has recently received the drug registration certificate issued by the National Medical Products Administration for the registered compound polyethylene glycol (3350) electrolyte oral solution. The related indications are for treating chronic constipation and fecal impaction.
Sunflower Pharmaceutical Group (002737.SZ) announced that its subsidiary recently received a drug registration certificate issued by the National Medical Products Administration for the approval of polyethylene glycol (3350) electrolyte oral solution. The indication is for the treatment of chronic constipation and fecal impaction.
Related Articles

Hunan Kylinsec Technology (688152.SH) adds Shi Yong and Xia Hua as core technical personnel.

SIS INT'L (00529): SiS Thai's shareholder's net income for the fiscal year 2025 was 876 million Thai baht, an increase of 25.63% year-on-year.

Guangdong Shaoneng Group's subsidiary signed an independent energy storage power station project land and power plant resource cooperation agreement.
Hunan Kylinsec Technology (688152.SH) adds Shi Yong and Xia Hua as core technical personnel.

SIS INT'L (00529): SiS Thai's shareholder's net income for the fiscal year 2025 was 876 million Thai baht, an increase of 25.63% year-on-year.

Guangdong Shaoneng Group's subsidiary signed an independent energy storage power station project land and power plant resource cooperation agreement.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


